{
  "url": "https://www.law.cornell.edu/regulations/new-york/8-NYCRR-29.7",
  "title": "N.Y. Comp. Codes R. & Regs. Tit. 8 ยง 29.7 - Special provisions for the professions of pharmacy and registered pharmacy technicians",
  "content": "N.Y. Comp. Codes R. & Regs. Tit. 8 ยง 29.7 - Special provisions for the professions of pharmacy and registered pharmacy technicians\n\nState Regulations\n(a) The\nrequirements of this section set forth for written prescriptions shall also be\napplicable to electronic prescriptions, as de fined in section\n63.6\n(a)(7)(i)(a)\nof this Title, unless otherwise indicate d. For purposes of this section\nsignature shall include an electronic signature, as defined in section\n63.6\n(a)(7)(i)(c)\nof this Title, when applicable, and sign shall include the affixing of an\nelectronic signature. Unprofessional conduct in the practice of pharmacy shall\ninclude all conduct prohibited by sections\n29.1\nand\n29.2\nof this Part except as\nprovided in this section, and shall also include the following: (1)\n\nDispensing a written prescription which\ndoes not bear the name, address and age of the patient for whom it is intended; the date on which it was written; the name, strength, if applicable, and the\nquantity of the drug prescribed; directions for use, if applicable; and, the\nname, address, telephone number, profession and signature of the prescriber; provided that the pharmacist may record on the prescription the address and age\nof the patient, the strength and quantity of the drug prescribed, the\ndirections for use and the prescriber's address, telephone number and\nprofession if these are missing or unclear. If the address and age of the\npatient and the address, telephone number and profession of the prescriber are\nmissing from the prescription, the pharmacist shall not be required to enter\nany of these items on the prescription if the information is otherwise readily\navailable in the records of the pharmacy. Prescription labels must be legible. An order for a drug to be dispensed for an inpatient in a health care facility\nby the pharmacy of that facility may be transmitted to the pharmacy in\naccordance with written procedures approved by the medical or other authorized\nboard of the facility. The items of information required by this paragraph\nwhich are found in the records regularly maintained by the facility and which\nare not essential to the execution of the order need not appear on the order\nwhich is transmitted to the pharmacy. A drug which is dispensed for an\ninpatient in a health care facility by the pharmacy of that facility may be\nlabeled in accordance with the policy adopted by the medical or other\nauthorized board of the facility. That policy shall insure that all the\ninformation required by law to be placed on prescription labels is readily\navailable to all concerned parties and that accuracy and safety prevail in the\ndispensing process. The address of a patient in a hospital or other health care\nfacility may, for the purpose of a prescription, be that of the facility. An\norder for a drug for a particular patient issued by a practitioner authorized\nto prescribe, and transmitted to a pharmacy for dispensing, shall constitute a\nprescription. Prescriptions written for controlled substances shall meet the\nrequirements of article 33 of the Public Health Law. (2)\n\nFailure by a pharmacist to reduce to\nwriting, either through written communication or electronic record, a\nprescription transmitted orally, which writing or electronic record shall\ninclude all the information required by paragraph (1) of this subdivision and\nthe signature, or the electronic equivalent of a signature, or readily\nidentifiable initials of the receiver of the oral prescription, provided that\noral prescriptions for controlled substances shall meet the requirements of\narticle 33 of the Public Health Law. (3)\n\nFailure by a pharmacist dispensing a\nprescription to enter on the prescription the date of dispensing and to sign or\ninitial legibly the prescription in such a manner as not to interfere with any\nother information on the prescription; provided that when the prescription is\ndispensed by an intern, the prescription shall bear the signature or readily\nidentifiable initials of the intern and of the pharmacist who is supervising\nthe intern. (4)\n\nRefilling a\nprescription without entering on the reverse of the prescription or within the\nelectronic record the date of the refill and the signature or readily\nidentifiable initials of the pharmacist and of the intern, if applicable, dispensing the refill, except as provided in paragraph (8) of this subdivision. As a refill instruction, the pharmacist may accept a number of times, a time\nperiod, such as one year, or the Latin phrase\npro re nata\n(abbreviated prn-meaning \"as needed\"). In the case of the latter, the\npharmacist shall refill the prescription once only. The pharmacist receiving on\noral order to refill a prescription shall reduce the order to writing or to an\nelectronic record and shall sign or initial it legibly as the recipient of the\noral order. When a prescription is refilled, the date placed on the label shall\nbe the date of the refill. (5)\n\nUsing or substituting without authorization one or more drugs in the place of\nthe drug or drugs specified in a prescription. Unauthorized use or substitution\noccurs if the same is done without the knowledge and consent of the prescriber. If other than the ingredients specified are utilized by the pharmacist in\ncompounding or dispensing the prescription, improper substitution shall be\npresumed unless there shall be entered upon the reverse of the original\nprescription or within the electronic record information setting forth the\nfacts of the substitution, the date, time and manner in which authorization for\nsubstitution was given and the signature of the pharmacist who received such\nauthorization. (6)\n\nFailure to\nidentify a generic product or interchangeable biological product dispensed on a\nprescription by writing the name of the manufacturer and of the distributor, if\ndifferent, on the prescription and on the label, except as otherwise provided\nin Education Law, sections 6816a(1)(c) and 6816-a(3)(c). (7)\n\nFailure to number prescriptions\nconsecutively and file them in a numerical or other form which provides for\nready retrieval of the prescriptions; provided that orders for drugs to be\ndispensed for inpatients in a health care facility, including but not limited\nto a general hospital, in the pharmacy of that facility under a drug\ndistribution system approved by the medical or other authorized board of the\nfacility, need not be numbered if the orders are otherwise readily available\nand retrievable; and, provided further that prescriptions for controlled\nsubstances shall be filed in accordance with the provisions of article 33 of\nthe Public Health Law. (8)\n\nFailure\nto maintain in a form which provides for ready retrieval of prescriptions a\ndaily record of all prescriptions filled and refilled which identifies clearly\nthe practitioner who ordered the prescription, the patient for whom the\nprescription is intended, the signature or readily identifiable initials of the\npharmacist who filled or refilled the prescription, and the number assigned to\nthe prescription where applicable. The record of the dispensing of a drug for\nan inpatient in a health care facility, including but not limited to general\nhospital, by the pharmacy of that facility may be maintained in a form which is\nconsistent with the record of the total health service provided to the patient\nprovided the information required by this paragraph is readily retrievable and\navailable. Original prescriptions filed in accordance with the provisions of\nparagraph (7) of this subdivision may constitute the record of the initial\nfilling of those prescriptions. The daily record may be maintained by a manual\nsystem or, alternatively, by an electronic data processing system which meets\nthe following requirements: (i) The system\nshall provide adequate safeguards against improper manipulation or alteration\nof stored records. (ii)\n\nArrangements shall be made which assure completeness and continuity of\nprescription records if the relationship between a pharmacy and a supplier of\ndata processing services terminates for any reason. (iii)\n\nThe system shall provide retrieval of\ninformation regarding original dispensing and the refilling of\nprescriptions. (iv)\nA pharmacist, and a pharmacy intern, if applicable, using a computerized system shall sign or\ninitial the original prescription at the time of the first dispensing as\nprovided in paragraph (3) of this subdivision and the signature or initials of\nthe pharmacist shall be entered into the computer record of the\ndispensing. (v) For all refills of\na prescription, the records introduced into the system shall be sufficient if: (a) the signature or initials of the\npharmacist who dispensed the refill are entered by such pharmacist at the time\nof dispensing; and\n(b) a printout\nor electronic record is produced of all prescriptions filled and refilled each\nday and the pharmacist(s) whose signature or initials appear(s) on the printout\nsign(s), either manually or electronically, the printout or electronic record\nto indicate that it is an accurate record. (vi)\nA pharmacy that employs a computerized\nsystem shall have an auxiliary procedure which shall be used for documentation\nof all new and refilled prescriptions dispensed during system downtime. The\nauxiliary procedure shall provide for the entry into the computer of all data\ncollected during the downtime, and the pharmacist shall insure that the maximum\nnumber of refills authorized on the original prescription has not been\nexceeded. (vii)\n\nOnly pharmacists\nand pharmacy interns shall enter prescription data into the computerized system\nand access the data, except as provided in paragraph (21) of this\nsubdivision. (9)\n\nExcept\nas otherwise provided in 16 CFR part\n1700\n(\nCode of Federal\n\nRegulations, 1984 edition, Superintendent of Public Documents, U.S. Government Printing Office, Washington, DC 20402: 1984, available at New York\n\nState Board of Pharmacy, Room 3035, Cultural Education Center, Albany, NY\n12230), failure to package a drug in a child-resistant container unless either\nthe prescriber or the patient requests otherwise. Such request shall be\ndocumented in the records of the pharmacy. Child-resistant containers shall not\nbe reused. (10)\n\nFailure by a\nsupervising pharmacist to provide adequate supervision of a registered\nestablishment. A supervising pharmacist must be a full-time employee of the\nestablishment. For the purposes of this section, full-time shall be deemed to\nbe 30 or more hours per week. In those circumstances in which an establishment\noperates for less than 30 hours per week, the supervising pharmacist shall be\nemployed for a majority of the hours that the establishment operates. The State\n\nBoard of Pharmacy shall be notified within seven days of any change in the\nidentity of the supervising pharmacist of a registered establishment. Such\nnotification shall be made by the owner of the registered\nestablishment. (11)\n\nAdvertisements\nof the prices of prescription drugs which do not comply with the following\nprovisions: (i) The advertised price shall be\nin effect for a period of time stated in the advertisement. (ii)\n\nWhen the advertising of prescription\nprices forms part of a larger advertisement which includes the offering of\ngeneral merchandise, the advertising pertaining to prescription prices shall be\nseparated physically, such as by a box, from the advertising pertaining to\ngeneral merchandise. (iii)\n\nNothing\nin this subdivision shall be construed to prevent the use in advertising of a\nstatement to the effect that the price for which any prescription will be\nfilled is available on request. (iv)\n\nSuch advertisement shall comply with the\n\"Prescription Drug Consumer Price Listing\" requirements set forth in section\n200.200 of title 21 of the\n\nCode of Federal Regulations\n(1984\nedition, Superintendent of Documents, U.S. Government Printing Office, Washington, DC 20402: 1984, available at New York State Board of Pharmacy, Room\n3035, Cultural Education Center, Albany, NY 12230). (12)\n\nAdvertising or soliciting professional\npractice by means of providing physicians, or others authorized to prescribe, with prescription blanks imprinted with either the name of the pharmacist or\nthe name of the pharmacy. (13)\n\nFailing to make prescription fee or price information readily available by\nproviding such information upon request and upon the presentation of a\nprescription for pricing or dispensing. Nothing in this section shall be\nconstrued to prohibit the quotation of price information on a prescription drug\nto a potential consumer by telephone. (14)\n\nPlacing in stock of any pharmacy any\npart of any prescription compounded or dispensed which is returned by a\npatient; provided, however, that in a health care facility, including but not\nlimited to a general hospital, which has its own pharmacy and in which\nunit-dose medication is dispensed to inpatients, each dose being individually\nsealed and labeled with the name of the drug, dosage strength, manufacturer's\ncontrol number and expiration date, the unused unit dose of medication may be\nreturned to the pharmacy of the facility for redispensing; and provided further\nthat unused medication may be returned to pharmacies by residential health care\nfacilities in accordance with the provisions of 10 NYCRR\n415.18\n(f) or by other\nfacilities, including but not limited to county correctional facilities, provided that such other facilities utilize standards, policies and procedures\ndetermined by the State Board of Pharmacy to be equivalent to those enumerated\nin 10 NYCRR\n415.18\n(f). (15)\n(i) Repacking of drugs in a pharmacy, except\nby a pharmacist or under his/her immediate and personal supervision. Labels on\nrepacked drugs shall bear sufficient information for proper identification and\nsafety. A repacking record shall be maintained, including the name, strength, lot number, quantity and name of the manufacturer and/or distributor of the\ndrug repacked, the date of the repacking, the number of packages prepared, the\nnumber of dosage units in each package, the signature of the person performing\nthe repackaging operation, the signature of the pharmacist who supervised the\nrepacking, and such other identifying marks added by the pharmacy for internal\nrecordkeeping purposes. Drugs repacked for in-house use only shall have an\nexpiration date of 12 months, or 50 percent of the time remaining to the\nmanufacturer's expiration date, whichever is less, from the date of repacking. For the repacking of drugs by manufacturers and wholesalers, the provisions of\nparts 210 and 211 of title 21, Code of Federal Regulations\n(1984 edition, Superintendent of Documents, U.S. Government Printing Office, Washington, DC 20402: 1984, available at New York State Board of Pharmacy, 89\n\nWashington Avenue, 2nd Floor, Albany, NY 12234), shall apply. Repacking records\nshall be maintained for five years and shall be made available to the\ndepartment for review and copying. (ii)\n\nRepacking drugs in customized patient\nmedication packages (patient med-pak or patient medication package) unless the\nfollowing conditions are complied with: (a) medications are packaged in moisture-proof containers that are either\nnon-reclosable or are designed to show evidence of having been\nopened; (b) medications are\ndispensed in containers that bear a label affixed to the immediate container in\nwhich the medications are dispensed in accordance with section\n6810\n(1)\nof the Education Law. Such label shall\ninclude: (1)\nall information required by\n\nEducation Law section 6810(1); (2)\nthe name, strength, physical description or identification, and quantity of\neach medication; (3)\nthe address\nand telephone number of the dispenser; (4)\nan expiration date for the customized\npatient medication package, which shall not be longer than the shortest\nrecommended expiration date of the medications included therein, provided that\nin no event shall the expiration date be more than 60 days from the date of\npreparation of the package and shall not exceed the shortest expiration date on\nthe original manufacturer's bulk containers for the dosage forms included\ntherein; (5)\na separate identifying\nserial number for each of the prescription orders for each of the drug products\ncontained in the customized patient medication package and, unless such number\nprovides complete information about the customized patient medication package, a serial number for the customized patient medication package itself; and\n(6)\nany other information, including storage instructions or any statements, or warnings required for the\nmedications contained in the package; (c) medications shall not be repackaged for\nor reissued to any patient other than to the patient for whom they are\noriginally dispensed; (d) medications shall not be dispensed in customized patient medication packages, without the consent of the patient, the patient's caregiver, or the prescriber, and the patient or caregiver shall be properly instructed in the use of such\npackages, in how to identify each medication, and in the steps to be taken in\nthe event one of the medications is discontinued or the therapy otherwise\naltered; (e) controlled substances\nshall not be dispensed in customized patient medication packages; (f) medications that are unstable or\ntherapeutically incompatible shall not be dispensed in customized patient\nmedication packages; and\n(g) a\nrecord of each customized patient medication package shall be maintained by the\npharmacist. Each record shall contain: (1)\nthe name and address of the patient; (2)\nthe serial number of the prescription\norder for each medication contained therein, or other means of individualized\ntracking system acceptable to the department; (3)\nthe name of the manufacturer or labeler\nand the lot number for each medication contained therein; (4)\ninformation identifying or describing the\ndesign, characteristics, or specifications of the customized patient medication\npackage sufficient to allow subsequent preparation of an identical customized\npatient medication package for the patient; (5)\nthe date of preparation of the customized\npatient medication package and the expiration date that was assigned; (6)\nany special labeling instructions; and\n(7)\nthe name or initials of the\npharmacist who prepared the customized patient medication package. (16)\n\nHolding\nfor sale, offering for sale and selling adulterated and/or misbranded drugs, devices and cosmetics. Any drug, device or cosmetic shall be deemed to be\nadulterated and/or misbranded if: (i) it is\nnot manufactured in accordance with the good manufacturing practices specified\nin parts 210 and 211 of title 21, Code of Federal Regulations\n(1984 edition, Superintendent of Documents, U.S. Government Printing Office, Washington, DC 20402: 1984, available at New York State Board of Pharmacy, Room\n3035, Cultural Education Center, Albany, NY 12230), provided that a drug\nmanufactured by a pharmacy for in-house use may be manufactured in accordance\nwith protocols, including documentation by means of a batch record, which\ninsure the meeting of established standards for purity and potency; and\n(ii)\nat any time it fails to\nmeet standards for purity, potency, labeling, safety and effectiveness\nestablished under the Federal Food, Drug and Cosmetic Act, as amended (June\n1981, Superintendent of Public Documents, U.S. Government Printing Office, Washington, DC 20402, available at New York State Board of Pharmacy, Room 3035, Cultural Education Center, Albany, NY 12230). (17)\n\nHolding for sale, offering for sale, or\nselling: (i) any drug later than the date, if\nany, marked upon the label as indicative of the date beyond which the contents\ncannot be expected beyond reasonable doubt to be safe and effective and/or\nbeyond use date, which shall mean the expiration date of the\ndrug; provided, however, that when such drug is identified as an outdated drug\nby segregation from regular stock or by other means, the holding of such drug\nbeyond its expiration date shall not be deemed a violation of this paragraph. When the expiration date is expressed by month and year, the expiration date\nshall be the last day of the month indicated; or\n(ii)\nany drug, the nature of which requires\nstorage under special conditions of temperature control as indicated either on\nthe labeling, in the directions for storage of said drug contained in an\nofficial compendium, or as directed by common prudence, unless such special\ncondition of temperature control shall have been complied with during the\nentire period of time in which such drug has been held for sale. (18)\n\nThe sale of drugs at auction\nwithout filing with the State Board of Pharmacy, at least seven days prior to\nthe date of said auction, a notice giving the date, time and place of the\nauction. At such auction, drugs in bulk or in open containers may be sold in\none lot only to a registered pharmacy. The drugs shall be removed to the\npremises of the purchaser promptly and the board notified as to the disposition\nof such drugs; provided, however, that drugs found, by the representative of\nthe board assigned to such auction, to be unfit for human use by virtue of age, adulteration and/or misbranding shall be destroyed voluntarily in the presence\nof the said representative or shall be quarantined by the representative\npending action for seizure and destruction. (19)\n\nHolding for sale, offering for sale, selling or distributing a new drug or an investigational new drug, which is not\nrecognized as a new drug or an investigational new drug under the provisions of\npart 310 or 312 of title 21, Code of Federal Regulations\n(1984\nedition, Superintendent of Public Documents, U.S. Government Printing Office, Washington, DC 20402: 1984, available at New York State Board of Pharmacy, Room\n3035, Cultural Education Center, Albany, NY 12230). (20)\n\nAbandoning the premises of a registered\nestablishment. Premises shall be deemed abandoned if the registrant vacates the\npremises without surrendering the certificate of registration to the State\n\nBoard of Pharmacy and without making appropriate arrangements for the disposal\nof prescription-required drugs. (21)\n\nAiding and abetting an unlicensed person\nto dispense drugs. (i) Subject to the\nlimitations set forth in subparagraph (ii) of this paragraph, an unlicensed\nperson may assist a pharmacist in the dispensing of drugs by: (a) receiving written or electronically\ntransmitted prescriptions, except that in the case of electronically\ntransmitted prescriptions the pharmacists or pharmacy intern shall review the\nprescription to determine whether in his or her professional judgment it shall\nbe accepted by the pharmacy, and if accepted, the pharmacist or pharmacy intern\nshall enter his or her initials into the records of the pharmacy; (b) typing prescription labels; (c) keying prescription data for entry into a\ncomputer-generated file or retrieving prescription data from the file, provided\nthat such computer-generated file shall provide for verification of all\ninformation needed to fill the prescription by a pharmacist prior to the\ndispensing of the prescription, meaning that the pharmacist shall review and\napprove such information and enter his or her initials or other personal\nidentifier into the recordkeeping system prior to the dispensing of the\nprescription or of the prescription refill; (d) getting drugs from stock and returning\nthem to stock; (e) getting\nprescription files and other manual records from storage and locating\nprescriptions; (f) counting dosage\nunits of drugs; (g) placing dosage\nunits of drugs in appropriate containers; (h) affixing the prescription label to the\ncontainers; (i) preparing manual\nrecords of dispensing for the signature or initials of the pharmacist; and\n(j) handing or delivering\ncompleted prescriptions to the patient or the person authorized to act on\nbehalf of the patient and, in accordance with section\n63.6\n(b)(8)\nof this\n\nTitle advising the patient or person authorized to act on behalf of the patient\nof the availability of counseling to be conducted by the pharmacist or pharmacy\nintern. (ii)\n\nLimitations\non assistance by a registered pharmacy technician and an unlicensed person. (a) No pharmacists, employed by a facility\nlicensed in accordance with Article 28 of the Public Health Law or a pharmacy\nowned and operated by such a facility, as defined in Article 137-A of Title\nVIII of the Education Law, shall obtain the assistance of more than two\nregistered pharmacy technicians in the performance of licensed tasks within\ntheir scope of practice or four unlicensed persons in the performance of the\nactivities that do not require licensure as set forth in clauses (i)(b)-(i) of\nthis paragraph, the total number of such persons shall not exceed four\nindividuals at one time. No pharmacist not employed by a facility licensed in\naccordance with Article 28 of the Public Health Law or a pharmacy not owned and\noperated by such a facility, as defined in Article 137-A of Title VIII of the\n\nEducation Law, shall obtain the assistance of more than [two] four unlicensed\npersons in the performance of the activities set forth in clauses (i)(b)-(i) of\nthis paragraph. Pharmacy interns shall be exempt from such ratios, but shall be\nsupervised in accordance with this Part and Part 63 of this Title. The\npharmacist shall provide the degree of supervision of such persons as may be\nappropriate to ensure compliance with the provisions of this Part and Part 63\nof this Title. Individuals who are responsible for the act of placing drugs\nwhich are in unit-dose packaging into medication carts as part of an approved\nunit-dose drug distribution system for patients in institutional settings shall\nbe exempt from such ratio, provided that such individuals are not also engaged\nin performing the activities set forth in clauses (i)(b)-(i) of this\nparagraph. (b) Unlicensed persons\nshall not be authorized to: (1)\nreceive oral\nprescriptions from prescribers; (2)\ninterpret and evaluate a prescription for conformance with legal requirements, authenticity, accuracy and interaction of the prescribed drug with other known\nprescribed and over-the-counter drugs; (3)\nmake determinations of the therapeutic\nequivalency as such determinations apply to generic substitution or interchange\nable biological product substitution; (4)\nmeasure, weigh, compound or mix\ningredients or engage in or assist in compounding; (5)\nsign or initial any record of dispensing\nrequired to be maintained by law; (6)\ncounsel patients; or\n(7)\nperform any other function involving the\nexercise of professional judgment. (c) No drug which is dispensed with the\nassistance of an unlicensed person, as provided in subparagraph (i) of this\nparagraph, shall be dispensed without the review and approval of the\npharmacist. (b) Nothing in this Part shall be construed\nto prevent the ownership of a firm or corporate practice in this State by an\nunlicensed person or persons or to prevent any contractual arrangement\ncomputing the salary of professional employees or the amount due the owner of\nsuch firm or corporation or a person leasing space or equipment to such firm or\ncorporation on the basis of a percentage of the receipts from the performance\nof professional services. This provision shall apply in lieu of section\n29.1\n(b)(4)\nof this\n\nPart. (c) The requirements of this\nsection and sections\n29.1\nand\n29.2\nof this Part shall be\napplicable to nonresident establishments, as defined in section\n6808-b\nof the\n\nEducation Law, to the extent prescribed in section\n63.8\nof this Title. Notes\nN.Y. Comp. Codes\nR. & Regs. Tit. 8\nยง\n29.7\n\nAmended, New\n\nYork State Register October 1, 2014/Volume XXXVI, Issue 39, eff. 10/1/2014\n\nAmended\n\nNew\n\nYork State Register April 25, 2018/Volume XL, Issue 17, eff. 4/25/2018\n\nAmended\n\nNew\n\nYork State Register May 26, 2021/Volume XLIII, Issue 21, eff. 5/26/2021\n\nState regulations are updated quarterly; we currently have two versions available. Below is a\ncomparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare. No prior version found.",
  "url_type": "regulation",
  "source_index": 40173
}